rights

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$ALT--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

4 months ago

UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$UNCY--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

4 months ago

EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30…

4 months ago

AOUT Investors Have Opportunity to Join American Outdoor Brands, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$AOUT--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

4 months ago

FCCO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of First Community Corporation is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of First Community Corporation (NASDAQ:…

4 months ago

LECTRA: Monthly declaration of the total number of shares and voting rights composing the company’s capital (at June 30th, 2025)

Monthly declaration of the total number of shares and voting rights composing the company's capital (at June 30th, 2025) This…

5 months ago

Monthly information on share capital and company voting rights

PARIS, July 04, 2025 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation of the French financial markets authority) Listing market:…

5 months ago

ENNOVI Achieves Prestigious EcoVadis Platinum Sustainability Rating for Unprecedented Fifth Year

Accolade aligns with ENNOVI's mission to positively impact the industries it serves SINGAPORE, June 17, 2025 /PRNewswire/ -- ENNOVI, an interconnect…

5 months ago

Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical…

5 months ago